Frazier Lifesciences Acquisition Corporation Unit

10.19-0.1100-1.07%Vol 2.41K1Y Perf 3.21%
Aug 5th, 2022 11:41 DELAYED
BID10.05 ASK10.19
Open10.19 Previous Close10.30
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
43.21 
Earnings Rating
Market Cap77.70M 
Earnings Date
-
Alpha-0.00 Standard Deviation0.02
Beta-0.07 

Today's Price Range

10.1710.25

52W Range

9.8410.65

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-1.55%
1 Month
2.93%
3 Months
2.57%
6 Months
2.72%
1 Year
3.21%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FLACU10.19-0.1100-1.07
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.41K
Shares Outstanding7.63K
Shares Float7.63M
Trades Count24
Dollar Volume24.69K
Avg. Volume4.26K
Avg. Weekly Volume470
Avg. Monthly Volume6.67K
Avg. Quarterly Volume5.63K

Frazier Lifesciences Acquisition Corporation Unit (NASDAQ: FLACU) stock closed at 10.19 per share at the end of the most recent trading day (a -1.07% change compared to the prior day closing price) with a volume of 2.41K shares and market capitalization of 77.70M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Diversified Financial Services industry, Financial Services sector and employs 4 people. Frazier Lifesciences Acquisition Corporation Unit CEO is James N. Topper.

The one-year performance of Frazier Lifesciences Acquisition Corporation Unit stock is 3.21%, while year-to-date (YTD) performance is 2.72%. FLACU stock has a five-year performance of %. Its 52-week range is between 9.84 and 10.65, which gives FLACU stock a 52-week price range ratio of 43.21%

Frazier Lifesciences Acquisition Corporation Unit currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of 1.97%, a ROC of 2.07% and a ROE of 2.09%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Frazier Lifesciences Acquisition Corporation Unit, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Frazier Lifesciences Acquisition Corporation Unit’s next earnings report date is -.

The consensus rating of Wall Street analysts for Frazier Lifesciences Acquisition Corporation Unit is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Frazier Lifesciences Acquisition Corporation Unit stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Frazier Lifesciences Acquisition Corporation Unit has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Frazier Lifesciences Acquisition Corporation Unit has a Buy technical analysis rating based on Technical Indicators (ADX : 16.36, ATR14 : 0.10, CCI20 : 99.91, Chaikin Money Flow : 0.10, MACD : 0.02, Money Flow Index : 78.67, ROC : 2.93, RSI : 32.91, STOCH (14,3) : 47.69, STOCH RSI : 0.00, UO : 38.36, Williams %R : -52.31), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Frazier Lifesciences Acquisition Corporation Unit in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Frazier Lifesciences Acquisition Corporation Unit

Frazier Lifesciences Acquisition Corp is a blank check company.

CEO: James N. Topper

Telephone: +1 206 621-7200

Address: 601 Union Street, Seattle 98101, WA, US

Number of employees: 4

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

58%42%

Bearish Bullish

53%47%

Bearish Bullish

55%45%


News

Stocktwits